RT Journal Article
SR Electronic
T1 Diabetes therapy and cancer risk: Where do we stand when treating patients?
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 620
OP 628
DO 10.3949/ccjm.81a.13140
VO 81
IS 10
A1 Grace E. Ching Sun
A1 Sangeeta R. Kashyap
A1 Christian Nasr
YR 2014
UL http://www.ccjm.org/content/81/10/620.abstract
AB The pathophysiology of type 2 diabetes mellitus conveys increased cancer risk, and any antidiabetic drug may alter that risk in a favorable or unfavorable way. This article discusses the links between diabetes and cancer, the different agents available for treating diabetes, and the cancer risk associated with these therapies.